RS60118B1 - Postupak za pripremu 1-(4-(4-(3,4-dihloro-2-fluorofenilamino)-7-metoksikvinazolin-6-iloksi)piperidin-1-il)-prop-2-en-1-on hidrohlorida i intermedijeri koji se u njemu koriste - Google Patents

Postupak za pripremu 1-(4-(4-(3,4-dihloro-2-fluorofenilamino)-7-metoksikvinazolin-6-iloksi)piperidin-1-il)-prop-2-en-1-on hidrohlorida i intermedijeri koji se u njemu koriste

Info

Publication number
RS60118B1
RS60118B1 RS20200295A RSP20200295A RS60118B1 RS 60118 B1 RS60118 B1 RS 60118B1 RS 20200295 A RS20200295 A RS 20200295A RS P20200295 A RSP20200295 A RS P20200295A RS 60118 B1 RS60118 B1 RS 60118B1
Authority
RS
Serbia
Prior art keywords
methoxyquinazolin
fluorophenylamino
yloxy
piperidin
prop
Prior art date
Application number
RS20200295A
Other languages
English (en)
Inventor
Keuk Chan Bang
Young Ho Moon
Young Kil Chang
Original Assignee
Hanmi Science Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48044309&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RS60118(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hanmi Science Co Ltd filed Critical Hanmi Science Co Ltd
Publication of RS60118B1 publication Critical patent/RS60118B1/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/94—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
RS20200295A 2011-10-05 2012-10-05 Postupak za pripremu 1-(4-(4-(3,4-dihloro-2-fluorofenilamino)-7-metoksikvinazolin-6-iloksi)piperidin-1-il)-prop-2-en-1-on hidrohlorida i intermedijeri koji se u njemu koriste RS60118B1 (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR1020110101422A KR101272613B1 (ko) 2011-10-05 2011-10-05 1-(4-(4-(3,4-디클로로-2-플루오로페닐아미노)-7-메톡시퀴나졸린-6-일옥시)피페리딘-1-일)프로프-2-엔-1-온 염산염의 제조 방법 및 이에 사용되는 중간체
PCT/KR2012/008077 WO2013051883A2 (en) 2011-10-05 2012-10-05 Method for preparing 1-(4-(4-(3,4-dichloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)piperidin-1-yl)-prop-2-en-1-one hydrochloride and intermediates used therein
EP12838558.0A EP2763981B1 (en) 2011-10-05 2012-10-05 Method for preparing 1-(4-(4-(3,4-dichloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)piperidin-1-yl)-prop-2-en-1-one hydrochloride and intermediates used therein

Publications (1)

Publication Number Publication Date
RS60118B1 true RS60118B1 (sr) 2020-05-29

Family

ID=48044309

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20200295A RS60118B1 (sr) 2011-10-05 2012-10-05 Postupak za pripremu 1-(4-(4-(3,4-dihloro-2-fluorofenilamino)-7-metoksikvinazolin-6-iloksi)piperidin-1-il)-prop-2-en-1-on hidrohlorida i intermedijeri koji se u njemu koriste

Country Status (23)

Country Link
US (1) US8859767B2 (sr)
EP (2) EP2763981B1 (sr)
JP (1) JP5805880B2 (sr)
KR (1) KR101272613B1 (sr)
CN (2) CN110003174A (sr)
AU (1) AU2012319291B2 (sr)
BR (1) BR112014007718B1 (sr)
CA (1) CA2850055C (sr)
CY (1) CY1122758T1 (sr)
DK (1) DK2763981T3 (sr)
ES (1) ES2775197T3 (sr)
HR (1) HRP20200426T1 (sr)
HU (1) HUE048798T2 (sr)
IL (3) IL231911B (sr)
IN (1) IN2014DN03447A (sr)
LT (1) LT2763981T (sr)
MX (1) MX348815B (sr)
PL (1) PL2763981T3 (sr)
PT (1) PT2763981T (sr)
RS (1) RS60118B1 (sr)
RU (1) RU2563630C1 (sr)
SI (1) SI2763981T1 (sr)
WO (1) WO2013051883A2 (sr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101317809B1 (ko) 2011-06-07 2013-10-16 한미약품 주식회사 암세포의 성장을 억제하는 아마이드 유도체 및 비금속염 활택제를 포함하는 약학 조성물
KR20140096571A (ko) * 2013-01-28 2014-08-06 한미약품 주식회사 1-(4-(4-(3,4-디클로로-2-플루오로페닐아미노)-7-메톡시퀴나졸린-6-일옥시)피페리딘-1-일)프로프-2-엔-1-온의 제조방법
CN104513229A (zh) * 2013-09-28 2015-04-15 正大天晴药业集团股份有限公司 喹唑啉衍生物及其制备方法
WO2016150340A1 (zh) 2015-03-20 2016-09-29 正大天晴药业集团股份有限公司 喹唑啉衍生物的盐及其制备方法
CN112823153A (zh) * 2018-09-14 2021-05-18 韩美制药有限公司 喹唑啉化合物及其盐酸盐的结晶形式
KR101950942B1 (ko) * 2019-01-28 2019-02-22 한미약품 주식회사 1-(4-(4-(3,4-디클로로-2-플루오로페닐아미노)-7-메톡시퀴나졸린-6-일옥시)피페리딘-1-일)프로프-2-엔-1-온의 제조방법
US20210221792A1 (en) * 2020-01-16 2021-07-22 Hanmi Pharm Co., Ltd. Convergent synthesis of poziotinib derivative
WO2022043923A1 (en) * 2020-08-28 2022-03-03 Hanmi Science Co., Ltd. Synthesis of poziotinib derivative

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI324597B (en) * 2002-03-28 2010-05-11 Astrazeneca Ab Quinazoline derivatives
EP1670782B1 (en) * 2003-09-19 2007-02-14 AstraZeneca AB Quinazoline derivatives
GB0322409D0 (en) * 2003-09-25 2003-10-29 Astrazeneca Ab Quinazoline derivatives
WO2007068552A1 (de) * 2005-12-12 2007-06-21 Boehringer Ingelheim International Gmbh Bicyclische heterocyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung
TWI377944B (en) * 2007-06-05 2012-12-01 Hanmi Holdings Co Ltd Novel amide derivative for inhibiting the growth of cancer cells
WO2010122340A2 (en) * 2009-04-23 2010-10-28 Astrazeneca Ab Process 738

Also Published As

Publication number Publication date
EP2763981A4 (en) 2015-02-25
EP3611172A1 (en) 2020-02-19
IN2014DN03447A (sr) 2015-06-26
CA2850055A1 (en) 2013-04-11
US8859767B2 (en) 2014-10-14
AU2012319291B2 (en) 2016-03-31
IL259694B (en) 2022-04-01
RU2563630C1 (ru) 2015-09-20
IL259694A (en) 2018-07-31
LT2763981T (lt) 2020-05-25
CY1122758T1 (el) 2021-03-12
DK2763981T3 (da) 2020-03-16
PL2763981T3 (pl) 2020-08-10
US20140275534A1 (en) 2014-09-18
CA2850055C (en) 2016-05-17
CN103857672A (zh) 2014-06-11
ES2775197T3 (es) 2020-07-24
IL231911A0 (en) 2014-05-28
WO2013051883A3 (en) 2013-06-06
CA2850055E (en) 2013-04-11
PT2763981T (pt) 2020-03-25
SI2763981T1 (sl) 2020-07-31
HRP20200426T1 (hr) 2020-09-04
IL291738A (en) 2022-05-01
WO2013051883A2 (en) 2013-04-11
HUE048798T2 (hu) 2020-08-28
CN103857672B (zh) 2018-11-30
BR112014007718B1 (pt) 2022-02-22
KR101272613B1 (ko) 2013-06-10
AU2012319291A1 (en) 2014-05-22
EP2763981A2 (en) 2014-08-13
JP5805880B2 (ja) 2015-11-10
BR112014007718A2 (pt) 2017-04-25
CN110003174A (zh) 2019-07-12
IL231911B (en) 2018-06-28
KR20130037079A (ko) 2013-04-15
MX2014003959A (es) 2014-05-14
EP2763981B1 (en) 2020-01-08
JP2014528444A (ja) 2014-10-27
MX348815B (es) 2017-06-30

Similar Documents

Publication Publication Date Title
IL291738A (en) Production method for 1-(4-(4-(4,3-dichloro-2-fluorophenylamino)-7-methoxyquinazoline-6-yloxy-piperidin-1-yl)-prop-2-en-1-one hydrochloride and intermediates used for this
HRP20190398T1 (hr) Čvrsti oblik (s)-3-(4-((4-morfolinometil)benzil)oksi)-1-oksoizoindolin-2-il)piperidin-2,6-dion hidroklorida
SI2800746T1 (sl) Postopek za proizvodnjo 1-(2-(2,4-dimetil-fenilsulfanil)-fenil-piperizina
EP2687510A4 (en) PROCESS FOR THE PREPARATION OF 2,3-DICHLORPYRIDINE
HK1199022A1 (zh) -三唑- -基 苯甲酰胺及 -三唑- -基 吡啶酰胺衍生物
EP2679592A4 (en) NEW HETEROCYCLIC COMPOUND, PROCESS FOR PRODUCING INTERMEDIATE PRODUCTS THEREOF AND USE THEREOF
IL267303B (en) Method for the production of -7-(3,4-dichloro-2-fluorophenylamino)-4)-4)-1 methoxyquinazolin-6-yloxy)piperidin-1-yl)prop-2-en-1-one
EP2474533A4 (en) 1- (SUBSTITUTED BENZYL) -5-TRIFLUOROMETHYL-2- (1H) PYRIDONE COMPOUNDS, THEIR SALTS, MANUFACTURING METHOD AND USES
BR112013000758A2 (pt) processo para preparar- 5 amino -3- ciano-1- (2,6 dicloro-4 triflúor metil fenil)-4- triflúor metil sulfinil-pirazol
IL236081A (en) METHOD FOR PRODUCING 4- [5- (pyridine-4-ram) -1,2,4- h1- triazole-3-ram] pyridine-2-carbonitrile and intermediate phase thereof
HK1213262A1 (zh) 二氧戊環- -基甲基 -吡唑- -胺的製備方法
ME02120B (me) Novi postupak za sintetiziranje (2e)- 3 -(3,4-dimetoksifenil)prop-2-en nitrila i uporaba za sintetiziranje ivabradina i njegovih dodatnih soli s farmaceutski prihvatljivom kiselinom
PL394559A1 (pl) Kapsulki zawierajace 4-[(4-metylopiperazyn-1ylo)metylo]-N-[4-metylo-3-[(4-pirydyn-3-ylopirymidyn-2-ylo)amino]fenylo]benzamid oraz sposób jej wytwarzania
IL238829A0 (en) Process for the preparation of 4-(cyclopropylmethoxy-3,5)-n-(dichloro-1-oxido-4-pyridyl)-5-methoxypyridine-2-carboxamide
SI2354133T1 (sl) Postopek za pripravo 1-(3-ciano-3,3-difenilpropil)-4-(1-piperidil)-piperidin-4- karboksamida (piritramida)
TH1401006705A (th) วิธีการสำหรับการเตรียม 2-(2,3-ไดเมททิลฟีนิล)-1-โพรพานัล (2-(2,3-dimethylphenyl)-1-propanal)